These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25662987)

  • 1. Comparison of 'anatomically designed' and 'point-by-point' catheter ablations for human atrial fibrillation in terms of procedure timing and costs in German hospitals.
    Klein G; Lickfett L; Schreieck J; Deneke T; Wieczorek M; ; Burkowitz J; Alvarez-Ossorio L; Brüggenjürgen B
    Europace; 2015 Jul; 17(7):1030-7. PubMed ID: 25662987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early experience with the cryoablation balloon procedure for the treatment of atrial fibrillation by an experienced radiofrequency catheter ablation center.
    Mandell J; Amico F; Parekh S; Snow J; Germano J; Cohen TJ
    J Invasive Cardiol; 2013 Jun; 25(6):288-92. PubMed ID: 23735354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of 200 consecutive, fluoroless atrial fibrillation ablations using a new technique.
    Liu X; Palmer J
    Pacing Clin Electrophysiol; 2018 Nov; 41(11):1404-1411. PubMed ID: 30194724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of atrial fibrillation with cryoballoon or duty-cycled radiofrequency pulmonary vein ablation catheter: a randomized controlled study comparing the clinical outcome and safety; the AF-COR study.
    Malmborg H; Lönnerholm S; Blomström P; Blomström-Lundqvist C
    Europace; 2013 Nov; 15(11):1567-73. PubMed ID: 23703361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of the convergent procedure and catheter ablation for non-paroxysmal atrial fibrillation.
    Anderson LH; Black EJ; Civello KC; Martinson MS; Kress DC
    J Med Econ; 2014 Jul; 17(7):481-91. PubMed ID: 24693987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of resource utilization of pulmonary vein isolation: cryoablation versus RF ablation with three-dimensional mapping in the Value PVI Study.
    DeVille JB; Svinarich JT; Dan D; Wickliffe A; Kantipudi C; Lim HW; Plummer L; Baker J; Kowalski M; Baydoun H; Jenkins M; Chang-Sing P
    J Invasive Cardiol; 2014 Jun; 26(6):268-72. PubMed ID: 24907083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote-controlled magnetic pulmonary vein isolation using a new three-dimensional non-fluoroscopic navigation system: a single-centre prospective study.
    Da Costa A; Ben H'dech M; Romeyer-Bouchard C; Bisch L; Gate-Martinet A; Levallois M; Isaaz K
    Arch Cardiovasc Dis; 2013; 106(8-9):423-32. PubMed ID: 23906679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation.
    Ladapo JA; David G; Gunnarsson CL; Hao SC; White SA; March JL; Reynolds MR
    J Cardiovasc Electrophysiol; 2012 Jan; 23(1):1-8. PubMed ID: 21777324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience of atrial fibrillation ablation in a new cardiac centre using three-dimensional mapping and multielectrode duty-cycled radiofrequency ablation.
    Choo WK; Farwell D; Harris S
    Arch Cardiovasc Dis; 2011; 104(6-7):396-402. PubMed ID: 21798472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
    Aronsson M; Walfridsson H; Janzon M; Walfridsson U; Nielsen JC; Hansen PS; Johannessen A; Raatikainen P; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Levin LÅ
    Europace; 2015 Jan; 17(1):48-55. PubMed ID: 25341739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Cryoballoon Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation on Healthcare Utilization and Costs: An Economic Analysis From the FIRE AND ICE Trial.
    Chun KRJ; Brugada J; Elvan A; Gellér L; Busch M; Barrera A; Schilling RJ; Reynolds MR; Hokanson RB; Holbrook R; Brown B; Schlüter M; Kuck KH;
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Catheter ablation of atrial fibrillation: Health Technology Assessment Report from the Italian Association of Arrhythmology and Cardiac Pacing (AIAC)].
    Themistoclakis S; Tritto M; Bertaglia E; Berto P; Bongiorni MG; Catanzariti D; De Fabrizio G; De Ponti R; Grimaldi M; Pandozi C; Tondo C; Gulizia M
    G Ital Cardiol (Rome); 2011 Nov; 12(11):726-76. PubMed ID: 22048448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of First Procedure Success Rate on the Economics of Atrial Fibrillation Ablation.
    Mansour M; Karst E; Heist EK; Dalal N; Wasfy JH; Packer DL; Calkins H; Ruskin JN; Mahapatra S
    JACC Clin Electrophysiol; 2017 Feb; 3(2):129-138. PubMed ID: 29759385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immediate and long-term results of conventionally performed radiofrequency catheter ablations of paroxysmal atrial fibrillation].
    Lábrová R; Fiala M; Toman O; Spinar J
    Vnitr Lek; 2008 Oct; 54(10):953-60. PubMed ID: 19009761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional radiofrequency catheter ablation compared to multi-electrode ablation for atrial fibrillation.
    Gal P; Aarntzen AE; Smit JJ; Adiyaman A; Misier AR; Delnoy PP; Elvan A
    Int J Cardiol; 2014 Oct; 176(3):891-5. PubMed ID: 25156854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter-phased radiofrequency energy: 2-year follow-up and predictors of failure.
    Mulder AA; Wijffels MC; Wever EF; Boersma LV
    Europace; 2012 Jun; 14(6):818-25. PubMed ID: 22345375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Discrete Event Simulation to Model the Economic Value of Shorter Procedure Times on EP Lab Efficiency in the VALUE PVI Study.
    Kowalski M; DeVille JB; Svinarich JT; Dan D; Wickliffe A; Kantipudi C; Foell JD; Filardo G; Holbrook R; Baker J; Baydoun H; Jenkins M; Chang-Sing P
    J Invasive Cardiol; 2016 May; 28(5):176-82. PubMed ID: 26984931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost minimization analysis of catheter ablation for paroxysmal atrial fibrillation by catheter technology.
    Osorio J; Imhoff RJ; Mallow PJ; Hunter TD; Goldstein L; Rajendra A; Morales G
    J Comp Eff Res; 2019 Mar; 8(4):241-249. PubMed ID: 30628479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact-force guided radiofrequency vs. second-generation balloon cryotherapy for pulmonary vein isolation in patients with paroxysmal atrial fibrillation-a prospective evaluation.
    Jourda F; Providencia R; Marijon E; Bouzeman A; Hireche H; Khoueiry Z; Cardin C; Combes N; Combes S; Boveda S; Albenque JP
    Europace; 2015 Feb; 17(2):225-31. PubMed ID: 25186456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesh ablator vs. cryoballoon pulmonary vein ablation of symptomatic paroxysmal atrial fibrillation: results of the MACPAF study.
    Koch L; Haeusler KG; Herm J; Safak E; Fischer R; Malzahn U; Werncke T; Heuschmann PU; Endres M; Fiebach JB; Schultheiss HP; Schirdewan A
    Europace; 2012 Oct; 14(10):1441-9. PubMed ID: 22523379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.